Table S3. Therapeutic regimens and survival outcomes of the included studies.
| Authors | Group | No. | Type of gastrectomy | Resection margin | Lymphadenectomy | Chemotherapy | Complication | Peritoneal recurrence | Metastasis | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subtotal | Total | R0 | R1/R2 | D0 | D1 | ≥D2 | Lymph node | Vessel | Hepatic | Peritoneal | ||||||||
| Song et al. (4) | YG | 112 | – | – | 85 | 27 | – | – | – | – | – | – | – | – | – | – | ||
| OG | 358 | – | – | 260 | 98 | – | – | – | – | – | – | – | – | – | – | |||
| Cormedi et al. (5) | YG | 71 | – | – | – | – | – | – | – | 21 | – | – | – | – | – | – | ||
| OG | 223 | – | – | – | – | – | – | – | 59 | – | – | – | – | – | – | |||
| Tavares et al. (8) | YG | 23 | 4 | 19 | – | – | – | – | – | 9 | – | 3 | – | – | 1 | – | ||
| OG | 360 | 133 | 227 | – | – | – | – | – | 86 | – | 10 | – | – | 21 | – | |||
| Guan et al. (9) | YG | 1,349 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | ||
| OG | 46,521 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |||
| Isobe et al. (10) | YG | 169 | – | 52 | 112 | – | 3 | 30 | 119 | 69 | – | – | – | – | 4 | 33 | ||
| OG | 3,649 | – | 936 | 2,728 | – | 217 | 988 | 2,205 | 1,180 | – | – | – | – | 203 | 414 | |||
| Kim et al. (11) | YG | 137 | 78 | 47 | 101 | – | – | – | – | – | – | – | 70 | – | 5 | 21 | ||
| OG | 194 | 122 | 52 | 157 | – | – | – | – | – | – | – | 106 | – | 6 | 18 | |||
| Kunisaki et al. (12) | YG | 131 | 93 | 25 | 121 | – | – | 24 | 107 | – | – | 18 | 48 | 34 | 2 | 6 | ||
| OG | 918 | 644 | 274 | 827 | – | – | 280 | 638 | – | – | 61 | 397 | 332 | 22 | 44 | |||
| Liu et al. (13) | YG | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | ||
| OG | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |||
| Okamoto et al. (14) | YG | 34 | – | – | 15 | – | 10 | – | – | – | – | – | 19 | – | 2 | 13 | ||
| OG | 132 | – | – | 73 | – | 23 | – | – | – | – | – | 64 | – | 10 | 20 | |||
| Takatsu et al. (15) | YG | 126 | – | 32 | 114 | 22 | – | – | – | – | 14 | 6 | – | – | 1/114 | – | ||
| OG | 1,435 | – | 445 | 1,241 | 194 | – | – | – | – | 276 | 58 | – | – | 33/1,241 | – | |||
| Tekesin et al. (16) | YG | 92 | 17 | 32 | – | – | – | – | – | – | – | – | – | 29 | – | 26 | ||
| OG | 774 | 185 | 260 | – | – | – | – | – | – | – | – | – | 254 | – | 230 | |||
| Wang et al. (17) | YG | 21 | – | – | 19 | – | – | – | – | – | 4 | – | – | 20 | – | 76 | ||
| OG | 36 | – | – | 33 | – | – | – | – | – | 153 | – | – | 155 | – | 461 | |||
| Hsieh et al. (18) | YG | 115 | 84 | 31 | 101 | 14 | – | – | – | 82 | – | – | 12 | – | – | – | ||
| OG | 1,009 | 753 | 256 | 893 | 116 | – | – | – | 590 | – | – | 25 | – | – | – | |||
| Ma et al. (19) | YG | 125 | – | – | – | – | – | – | – | 96 | – | – | – | 43 | – | – | ||
| OG | 1,752 | – | – | – | – | – | – | – | 1,023 | – | – | – | 451 | – | – | |||
| Mitsudomi et al. (20) | YG | 128 | 13 | 29 | 103 | – | – | – | – | – | 9 | – | – | – | – | – | ||
| OG | 1,275 | 90 | 236 | 1,076 | – | – | – | – | – | 15 | – | – | – | – | – | |||
| Kulig et al. (21) | YG | 214 | 89 | 63 | 78 | 74 | – | 39 | 113 | – | 65 | – | – | – | – | – | ||
| OG | 3,217 | 1,195 | 898 | 1,146 | 947 | – | 641 | 1,452 | – | 1,058 | – | – | – | – | – | |||
| Bani-Hani et al. (22) | YG | 17 | – | – | 7 | – | – | – | – | – | – | – | – | – | – | – | ||
| OG | 159 | – | – | 66 | – | – | – | – | – | – | – | – | – | – | – | |||
| Kim et al. (23) | YG | 175 | – | – | 144 | 31 | – | – | – | – | – | – | 86 | – | – | – | ||
| OG | 1,124 | – | – | 888 | 236 | – | – | – | – | – | – | 566 | – | – | – | |||
| Lai et al. (24) | YG | 883 | 612 | 262 | – | – | – | – | – | – | – | – | – | – | – | – | ||
| OG | 6,071 | 4,491 | 1,519 | – | – | – | – | – | – | – | – | – | – | – | – | |||
| Maehara et al. (25) | YG | 174 | 112 | 62 | 125 | – | – | 32 | 141 | – | – | 15 | 95 | 15 | 2 | 23 | ||
| OG | 356 | 212 | 139 | 255 | – | – | 119 | 237 | – | – | 25 | 207 | 81 | 16 | 23 | |||
| Silva et al. (26) | YG | – | – | – | – | – | – | – | – | – | – | – | 38 | – | – | – | ||
| OG | – | – | – | – | – | – | – | – | – | – | – | 342 | – | – | – | |||
| Adachi et al. (28) | YG2 | 36 | – | – | – | – | – | – | – | – | 7 | – | 17 | – | 1/7 | 4/7 | ||
| OG3 | 68 | – | – | – | – | – | – | – | – | 25 | – | 33 | – | 3/24 | 7/24 | |||
| Bautista et al. (29) | YG | 46 | – | – | – | – | – | – | – | 31 | – | – | – | – | – | – | ||
| OG | 1,208 | – | – | – | – | – | – | – | 475 | – | – | – | – | – | – | |||
| Wang et al. (30) | YG | 342 | – | – | 327 | 15 | – | – | – | 267 | – | – | – | – | 16 | 13 | ||
| OG | 3,588 | – | – | 3,406 | 182 | – | – | – | 2,856 | – | – | – | – | 165 | 173 | |||
No., number of patients; YG, younger group; OG, older group; R, resection margin.